Gilead Sciences, Inc.(NASDAQ:GILD) today announced the launch of the Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative, a 10-year, $100 million commitment to support organizations working to address the HIV/AIDS epidemic in the Southern United States. Gilead will partner with three coordinating centers to lead the corporate giving program of the initiative: Emory University Rollins School of Public Health, the University of Houston Graduate College of Social Workand the Southern AIDS Coalition. These coordinating centers will identify and provide funding to local organizations that are committed to addressing the epidemic throughout the region, focusing on capacity building and shared knowledge; wellbeing, mental health and trauma-informed care